Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Jan 2009

Strous Rael D, Ritsner Michael S, Adler Shmuel, Ratner Yael, Maayan Rachel, Kotler Moshe, Lachman Herbert, Weizman Abraham

Abstract excerpt

S-adenosyl-methionine (SAM-e), functions as a primary methyl group donor for several metabolic compounds. Since SAM-e is involved in several metabolic processes, its administration may have a role in the amelioration of several disorders. In addition, SAM-e increases catechol-O-methyltransferase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aggression
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Norepinephrine

Share to Psychiatric Status Rating Scales

Share to Psychomotor Performance

Share to Quality of Life

Share to S-Adenosylmethionine

Share to Schizophrenic Psychology

Source

Identifiers

PMID: 18824331
DOI: 10.1016/j.euroneuro.2008.08.004

Genes

COMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18824331-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.PMID 18824331Read ↗

A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive ValiditySemantic proximity Read ↗

Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.Semantic proximity Read ↗

Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)Semantic proximity Read ↗

D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?Semantic proximity Read ↗

Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.Semantic proximity Read ↗

Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia.Semantic proximity Read ↗

Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior.Semantic proximity Read ↗

DNA methylation of membrane‐bound catechol‐O‐methyltransferase in Malaysian schizophrenia patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.